InspireMD, Inc. (NSPR) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcript
InspireMD to Participate in Upcoming Bank of America Securities 2026 Global Healthcare Conference
InspireMD, Inc. (NSPR) Reports Q1 Loss, Tops Revenue Estimates
InspireMD, Inc. (NSPR) Q1 2026 Earnings Call Transcript
InspireMD Reports First Quarter 2026 Financial Results
InspireMD Initiates Voluntary U.S. Recall of CGuard® Prime 135 cm Carotid Stent Delivery System
InspireMD Announces FDA Approval of Investigational Device Exemption Application for CGUARDIANS III Pivotal Study of the SwitchGuard Neuro Protection System
InspireMD to Announce First Quarter 2026 Financial Results
InspireMD to Announce First Quarter 2026 Financial Results
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of InspireMD, Inc. (NASDAQ: NSPR)
After Plunging 15.2% in 4 Weeks, Here's Why the Trend Might Reverse for InspireMD (NSPR)
InspireMD (NYSE:NSPR) Trading Down 6.7% – What’s Next?
InspireMD to Participate in Upcoming 25th Annual Needham Virtual Healthcare Conference
InspireMD, Inc. (NSPR) Q4 2025 Earnings Call Transcript
InspireMD, Inc. (NSPR) Reports Q4 Loss, Beats Revenue Estimates
InspireMD Reports Fourth Quarter and Full Year 2025 Financial Results
InspireMD to Announce Fourth Quarter and Full Year 2025 Financial Results
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
InspireMD Announces Publication of the C-GUARDIANS Pivotal Trial Manuscript in the Journal of the American College of Cardiology (JACC)
Head to Head Analysis: InspireMD (NYSE:NSPR) versus Minerva Surgical (NASDAQ:UTRS)
Landmark CREST-2 Study Published in the New England Journal of Medicine Highlights the Benefits of Carotid Artery Stenting
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
InspireMD to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference
InspireMD, Inc. (NSPR) Q3 2025 Earnings Call Transcript
InspireMD, Inc. (NSPR) Reports Q3 Loss, Tops Revenue Estimates
InspireMD Reports Third Quarter 2025 Financial Results
InspireMD Names Peter A. Soukas, M.D.
InspireMD to Announce Third Quarter 2025 Financial Results
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
InspireMD Announces the Appointment of Dan Dearen to its Board of Directors
InspireMD, Inc. (NSPR) Q2 2025 Earnings Call Transcript
InspireMD Reports Second Quarter 2025 Financial Results
InspireMD Announces the Appointment of Raymond W. Cohen to its Board of Directors
InspireMD Announces Combined Financings of $58 Million
InspireMD to Announce Second Quarter 2025 Financial Results
InspireMD Launches CGuard Prime Carotid Stent System in the U.S.
InspireMD Announces U.S. Commercial Launch of CGuard® Prime Carotid Stent System for the Prevention of Stroke
InspireMD Announces FDA Approval for CGuard® Prime Carotid Stent System for the Prevention of Stroke
InspireMD Announces CE Mark Approval for CGuard® Prime Embolic Prevention System (EPS) Under European MDR for the Prevention of Stroke
InspireMD Announces Appointment of Michael Lawless as Chief Financial Officer
InspireMD, Inc. (NSPR) Q1 2025 Earnings Call Transcript
InspireMD, Inc. (NSPR) Reports Q1 Loss, Tops Revenue Estimates
InspireMD Reports First Quarter 2025 Financial Results
InspireMD to Present at Upcoming Bank of America 2025 Healthcare Conference
InspireMD to Announce First Quarter 2025 Financial Results
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
InspireMD to Present at Upcoming 24th Annual Needham Virtual Healthcare Conference
InspireMD, Inc. (NSPR) Q4 2024 Earnings Call Transcript